| Dr. Nowak's Publications |
| Mason H.R., Lake A.C., Wubben J.E.,
Nowak R.A., Castellot J.J. Jr. The growth arrest-specific gene CCN5 is
deficient in human leiomyomas and inhibits the proliferation and motility
of cultured human uterine smooth muscle cells.
Molecular Human Reproduction
2004
10(3):181-7. |
| Mason H.R., Grove-Strawser D., Rubin B.S.,
Nowak R.A., Castellot J.J. Jr. Estrogen induces CCN5 expression in
the rat uterus in vivo.
Endocrinology
2004;145(2):976-82. |
| Gross K.L., Neskey D.M., Manchanda N.,
Weremowicz S., Kleinman M.S., Nowak R.A., Ligon A.H., Rogalla P.,
Drechsler K., Bullerdiek J., Morton C.C. HMGA2 expression in uterine
leiomyomata and myometrium: quantitative analysis and tissue culture
studies.
Genes Chromosomes Cancer
2003;38(1):68-79. |
| Mason H.R., Nowak R.A., Morton
C.C., Castellot J.J. Jr. Heparin inhibits the motility and proliferation
of human myometrial and leiomyoma smooth muscle cells.
American Journal of Pathology
2003;162(6):1895-904. |
| Propst A.M., Quade B.J., Nowak R.A.,
Stewart E.A. Granulocyte macrophage colony-stimulating factor in
adenomyosis and autologous endometrium.
J Soc Gynecol
Investig 2002;9(2):93-7. |
| Nowak, R.A. Identification of new therapies for leiomyomas: what
in vitro studies can tell us.
Clinical Obstetrics & Gynecology 2001;44:327-334. |
| Lee, B.S., and R.A. Nowak. Human leiomyoma smooth muscle cells show
increased expression of transforming growth factor-b3 (TGFb) and altered
responses to the anti-proliferative effects of TGFb.
Journal of Clinical Endocrinology
and Metabolism
2001;86:913-920 |
| Propst, A.M., B.J. Quade, A.R. Gargiulo,
R.A. Nowak, and E.A. Stewart. Adenomyosis demonstrates increased expression of the basic fibroblast
growth factor receptor/ligand system compared with autologous endometrium.
Menopause 2001 Sep-Oct;8(5):368-71. |
| Nowak, R.A. Novel therapeutic strategies for leiomyomas:
targeting of growth factors and their receptors.
Environmental Health Perspectives
2000;108 (suppl 5):849-853. |
| Nowak, R.A. Fibroids: pathophysiology and current medical
treatment. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999
Jun;13(2):223-38. Review. |
| Nowak, R.A., F. Haimovici, J.D. Biggers,
and G.T. Erbach. Transforming
growth factor-b stimulates mouse blastocyst outgrowth through a mechanism
involving parathyroid hormone-related protein (PTHrP).
Biology of Reproduction
1999;60:85-93. |
| Gattas, G.J.F., B.J. Quade, R.A. Nowak,
and C.C. Morton. HMGI-C expression in
human adult and fetal tissues and in uterine leiomyomas.
Genes,
Chromosomes and Cancer
1999;25:316-322. |
| Austin, D.J., R.A. Nowak, and E.A. Stewart. Onapristone suppresses
prolactin production in explant cultures of leiomyoma.
Gynecol Obstet
Invest. 1999;47(4):268-71. |
| Nowak, R.A., S. Mora, T. Diehl, A.R. Rhoades,
and E.A. Stewart. Prolactin is
an autocrine or paracrine growth factor for human myometrial and leiomyoma
cells. Gynecol Obstet Invest. 1999;48(2):127-32. |
| Lee, B.S., E. A. Stewart, M. Sahakian, and
R.A. Nowak. Interferon-alpha is a
potent inhibitor of basic fibroblast growth factor-stimulated cell
proliferation in human uterine cells.
American Journal of
Reproductive Immunology 1998;40:19-25. |
| Lee, B.S., S.B. Margolin, and R.A. Nowak. Pirfenidone: A novel
pharmacological agent that inhibits leiomyoma cell proliferation and
collagen production. Journal of
Clinical Endocrinology and Metabolism
1998;83:219-223. |
| Anania, C.A., E. A. Stewart, B.J. Quade,
J.A. Hill, and R.A. Nowak. Expression
of the fibroblast growth factor receptor in women with leiomyomas and
abnormal uterine bleeding.
Molecular
Human Reproduction
1997;3:685-691. |
|